Quote

To develop drugs for people, we basically dismantle the system. In the lab, we look at things the size of a cell or two. We dismantle life into very small models.

We're finally moving out of the realm of solely discussing biology in regards to a drug-based world.

Reducing the price of cancer drugs is a humanitarian move.

We are trying to find drugs, small molecules, that people could take to make them disease-resistant, more youthful and healthy. Eventually we will find them.

The biotech game is quickly changing. The people must demand their use of these treatments.

While we spend our life asking questions about the nature of cancer and ways to prevent or cure it, society merrily produces oncogenic substances and permeates the environment with them.

We're really going after truly creating sustainability of a disease-free state, creating a complete system for managing cancer patients for life, so that you can manage from onset of disease all the way through.

We're not going to find a magic cure for cancer. We've got to prevent it.

We should revel in tons and tons and tons of ideas. Some of them will manifest and lead to a drug discovery, and some will not.

Anybody that thought the genome was going to directly provide drugs was a fool. Biological networks are not simple, and making drugs to affect them won't be simple.